Why the study?
Comparisons of cardiorespiratory fitness across population studies are hindered by unstandardized exercise testing and estimation methods that assume steady-state exercise.
Does a generalized framework for estimating VO2max improve agreement with measured VO2max and associations with cardiometabolic risk factors compared to canonical estimation methods?
Does a generalized framework for estimating VO2max improve agreement with measured VO2max and associations with cardiometabolic risk factors compared to canonical estimation methods?
A novel generalized framework standardizes cardiorespiratory fitness estimation across diverse exercise tests, providing a more reliable biomarker of cardiometabolic health than traditional steady-state methods.
Answers are grounded in this paper and cite their sources.
New harmonised framework may standardise VO2max estimation across studies; leaves open prospective validation before clinical or research adoption.
Comparisons of cardiorespiratory fitness across population studies are hindered by a lack of standardisation in exercise testing and reliance on estimation methods that assume steady-state exercise. We developed a generalised framework that standardises maximal oxygen consumption estimation by harmonising dynamic heart rate modelling with individualised calibration of exercise energetics. We constructed and evaluated the framework using submaximal and maximal tests (treadmill walking and running, cycle ergometer, stepping, overground walking) from 911 adults. Agreement between framework estimates and directly measured was strong (non-significant bias, Pearson’s r=0.80). We then applied both framework and canonical methods to estimate in 11,307 UK Fenland Study adults and examined associations with cardiometabolic risk. Framework-estimated was more strongly associated with blood glucose, fasting insulin, and high-density lipoprotein cholesterol (combined risk factor model AIC=125,743) compared to canonical estimates (AIC=129,227). The framework standardises fitness estimation across diverse tests, yielding a more reliable and comparable biomarker of cardiometabolic health.
No takes yet. Share an insight, caveat, or question.
Gonzales et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: